As of September 8, 2023, CEO Damien McDonald of Enovis purchased 13,035 shares at $19.15 each, totaling $249,620, according to SEC filings. This buy comes after a previous purchase of shares for $199,973 at $30.97 each within the past year. Enovis’ stock has increased by 3.2% on the same day.
On September 7, 2023, David P. Hochman bought $47,900 worth of Orchestra BioMed Holdings, acquiring 10,000 shares at $4.79 each. Hochman’s previous investments in the past twelve months total $82,100 at an average price of $4.11 per share. The stock for Orchestra BioMed is trading up 2.9%, with Hochman currently seeing a 9.6% gain based on the day’s high of $5.25.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
